Erythema migrans

Medical Clinics of North America

Volumn 86, Issue 2, 2002, Pages 239-260

  Edlow, Jonathan A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SKIN DEFECT; SUNBURN;

EID: 0036227661     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00085-3     Document Type: Review

References (53)

1. Erythema chronica migrans, ticks and Lyme disease in Missouri
2. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics
3. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity
4. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: Possible agent of a Lyme disease-like illness
5. Comparison of azithromycin and doxycycline in the treatment of erythema migrans
6. Dermatologic manifestations of Lyme disease
7. Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease
8. Borrelia lonestari DNA in adult Amblyomma americanum ticks, Alabama
9. A prospective study of tick bites in an endemic area for Lyme disease
10. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease
11. Epidemiology, ecology, and prevention of Lyme disease
12. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis
13. Lyme disease and related tick-borne illnesses
14. Reinfection in Lyme borreliosis
15. Early Lyme disease: A flu-like illness without erythema migrans
16. Solitary erythema migrans in Georgia and South Carolina
17. Racial differences in reported Lyme disease incidence
18. Tick bites and Lyme disease in an endemic setting: Problematic use of serologic testing and prophylactic antibiotic therapy
19. Lyme disease in children in southeastern Connecticut
20. Vesicular erythema migrans
21. Bloodstream invasion in early Lyme disease: Results from a prospective, controlled, blinded study using the polymerase chain reaction
22. Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus
23. Binding of human plasminogen to Borrelia burgdorferi
24. Borrelia lonestari infection after a bite by an Amblyomma americanum tick
25. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi
26. Concurrent Lyme disease and babesiosis: Evidence for increased severity and duration of illness
27. Azithromycin compared with amoxicillin in the treatment of erythema migrans: A double-blind, randomized, controlled trial
28. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection
29. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans
30. Erythema migrans in pregnancy
31. Erythema chronicum migrans in the United States
32. Lyme and/or Lyme-like disease in Missouri
33. Management of tick bites and early Lyme disease
34. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite
35. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans
36. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease
37. Test-treatment strategies for patients suspected of having Lyme disease: A cost-effectiveness analysis
38. Failure of treatment with cephalexin for Lyme disease
39. Culture-confirmed infection and reinfection with Borrelia burgdorferi
40. Duration of tick attachment and Borrelia burgdorferi transmission
41. Erythema chronicum migrans
42. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites
43. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic
44. Lyme disease
45. Antibiotic therapy in Lyme disease
46. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three connecticut communities
47. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
48. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans
49. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia
50. Azithromycin versus doxycycline for treatment of erythema migrans: Clinical and microbiological findings
51. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis
52. Treatment failure in erythema migrans - A review
53. History of Lyme borreliosis in Europe